H1, a company focused on enhancing healthcare operations through AI, has secured a significant $40 million investment led by CVS Health Ventures. This funding aims to bolster their ongoing initiatives to improve healthcare provider connections and streamline patient access to care.
The investment from CVS Health Ventures, which is dedicated to fostering healthcare innovation, follows a series of successful collaborations between the two entities. Notably, they have developed an AI model that significantly enhances the accuracy of healthcare provider directories, facilitating quicker connections between patients and providers. Justin Brock, a Partner at CVS Health Ventures, emphasized that this partnership aligns with CVS's commitment to improving healthcare access and simplifying the overall experience.
H1's platform is designed to assist various stakeholders in the healthcare sector, including pharmaceutical companies and health plans, by identifying and engaging the appropriate medical professionals for specific needs. With a strong customer base—85% of the top 20 pharmaceutical companies and 90% of leading health plans—H1 is positioned for continued growth and profitability, aiming to operate above the Rule of 40 standard in 2026.
Ariel Katz, Co-Founder and CEO of H1, highlighted that this collaboration is pivotal for achieving their mission of connecting millions of Americans to the right healthcare providers. The partnership with CVS Health is expected to further enhance the accessibility and efficiency of healthcare services.